News Releases



TARRYTOWN, NY, January 18, 2006 - Hitachi America, Ltd., a subsidiary of Hitachi, Ltd., (NYSE: HIT) today announced that it is entering the market for pharmaceutical validation services through the acquisition of Validation Masters, Inc. (VMI,) a premier validation services company. Terms were not disclosed. The acquisition of the company is designed to augment and enhance Hitachi’s capabilities to provide total services to its clients in the pharmaceutical industry. The acquisition also makes the Hitachi Group the first company to have active operations in both the U.S. and Japanese pharmaceutical services markets, enabling Hitachi to provide truly global services.

VMI will be incorporated into Hitachi America’s Pharmaceutical Services Group and be known as Hitachi Validation Services. Paul Damurjian, president and founder of VMI will head the new unit and continue to execute current and future validation projects with proven and streamlined efficiency. He reports to Vito Cappello, P. E. director of the Pharmaceutical Services Group of Hitachi America. The new unit will be based at Hitachi offices in Basking Ridge, N.J.

In making the announcement, Masahide Tanigaki, executive vice president of Hitachi America said, “The acquisition of VMI is indicative of the strong synergy which exists between Hitachi and VMI. The company’s experience and capabilities, dedication to quality, flexibility and client service are the paramount elements our customers’ requirements. VMI brings these key elements to our Pharmaceutical Services Group. We intend to maintain the local focus and competitiveness while providing our clients with the potential of utilizing the broad technical, process, engineering and manufacturing, and financial strength of Hitachi.”

The company said that the validation scope of services will include Validation Master Plan Development along with Equipment, Facility and Computer Systems Qualification. Additionally, Environmental Monitoring, Cleaning Validation, Vendor Auditing and Validation Project Management services will be offered.

Hitachi Pharmaceutical is a global total solutions provider. Hitachi is dedicated to working in partnership with its global clients in order to bring future market product requirements to successful fulfillment by offering a total project solution with integrated, seamless services and products that include pilot plant and process simulation software, conceptual/basic/detailed engineering, worldwide procurement, construction, validation and final acceptance, project financing, process and utility equipment supply and fabrication and modularization facilities.

Hitachi has had a major presence in the Asian pharmaceutical industry since 1948. Hitachi has provided “total project solutions” to more than 200 bulk and bio-pharmaceutical projects including grassroots, revamp and expansion of commercial and research facilities related to mammalian cell culture, microbial culture, chemical synthesis, fill and finishing, pilot plants and R&D. For further information on Hitachi’s validation services, customers and prospects can call 908.605.2770 or visit

Hitachi America, Ltd., a subsidiary of Hitachi, Ltd., markets and manufactures a broad range of electronics, computer systems and products, and consumer electronics, and provides industrial equipment and services throughout North America. For more information, visit

Hitachi, Ltd., (NYSE: HIT / TSE: 6501), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 347,000 employees worldwide. Fiscal 2004 (ended March 31, 2005) consolidated sales totaled 9,027.0 billion yen ($84.4 billion). The company offers a wide range of systems, products and services in market sectors including information systems, electronic devices, power and industrial systems, consumer products, materials and financial services. For more information on Hitachi, please visit the company’s website at